# Insulin Glargine (Genetical Recombination) / Lixisenatide Injection (ソリクア配合注ソロスター)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 3969501G1023). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 3969501G1023
- **Product name (Japanese):** ソリクア配合注ソロスター
- **English title:** Insulin Glargine (Genetical Recombination) / Lixisenatide Injection
- **Active ingredient:** インスリングラルギン（遺伝子組換え）・リキシセナチド
- **Active ingredient (INN):** Insulin Glargine (Genetical Recombination) / Lixisenatide
- **Strength / unit:** １キット
- **Route:** Injection (注射薬)
- **Therapeutic category:** 39 Other metabolic agents (その他の代謝性医薬品) › 396 Antidiabetics (糖尿病用剤)
- **Manufacturer:** Sanofi (サノフィ)
- **NHI price (reference only):** JPY 4195 per １キット
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/3969501G1023
- **JSON:** https://www.nifujipharma.com/api/drugs/3969501G1023

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Insulin%20Glargine%20(Genetical%20Recombination)%20%2F%20Lixisenatide%20Injection%20(%E3%82%BD%E3%83%AA%E3%82%AF%E3%82%A2%E9%85%8D%E5%90%88%E6%B3%A8%E3%82%BD%E3%83%AD%E3%82%B9%E3%82%BF%E3%83%BC)%20%2F%20YJ%203969501G1023#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.